While medicinal inorganic chemistry has been practised for over 5000 years, it was not until
the late 1800s when Alfred Werner published his ground-breaking research on coordination …

Platinum-based anticancer drugs are among the most widely used antineoplastics in clinical
settings. Their therapeutic applications and outcomes are, however, greatly hampered by …

Ruthenium (II) polypyridyl complexes (RPCs) that emit from metal-to-ligand charge transfer
(MLCT) states have been developed as DNA probes and are being examined as potential …

More than 10 million death tolls in 2020 were reported as a result of heinous impact of
cancer, making it second most prime cause of death after cardiovascular diseases. In …

Heterometallic supramolecular polymers (HMSPs) comprising two or more heterometal ions
have drawn significant research interest in the last two decades because of their attractive …

The dinuclear photo-oxidizing RuII complex [{Ru (TAP2)} 2 (tpphz)] 4+(TAP= 1, 4, 5, 8-
tetraazaphenanthrene, tpphz= tetrapyrido [3, 2-a: 2′, 3′-c: 3 ″, 2′′-h: 2‴, 3′′′-j] …

Due to these limitations of platinum-based drugs, it has now become a challenge for
researchers to find out a potential scaffold furnished with indispensable properties like …

Drug resistance to platinum chemotherapeutics targeting DNA often involves abrogation of
apoptosis and has emerged as a significant challenge in modern, non-targeted …

Medicinal leads that are also compatible with imaging technologies are attractive, as they
facilitate the development of therapeutics through direct mechanistic observations at the …

Molecules | Free Full-Text | Editorial of Special Issue Ruthenium Complex: The Expanding
Chemistry of the Ruthenium Complexes Next Article in Journal The Guareschi Pyridine …